Leucadia National Corporation »

Pyxis Oncology shares owned by Leucadia National Corporation

Quarter-by-quarter ownership of Pyxis Oncology (PYXS) shares owned by Leucadia National Corporation from 13F filings

Historical chart of Leucadia National Corporation investment in Pyxis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Pyxis Oncology held by Leucadia National Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pyxis Oncology by Leucadia National Corporation

Quarter filed Position value Share count Share price at filing
2025-12-31 $18k 16k 1.15

More positions owned by Leucadia National Corporation

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr Gold Tr Gold Shs (GLD)
Iren Ordinary Shares (IREN)
NVIDIA Corporation (NVDA)
Ishares Tr Russell 2000 Etf (IWM)
Alphabet Cap Stk Cl C (GOOG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Citigroup Com New (C)
Amazon (AMZN)
Spdr Series Trust State Street Spd (XBI)
Apple (AAPL)
Select Sector Spdr Tr State Street Ene (XLE)
Alphabet Cap Stk Cl A (GOOGL)
Insmed Com Par $.01 (INSM)
Cidara Therapeutics Com New (CDTX)

View all positions for Leucadia National Corporation

Top funds holding Pyxis Oncology

Pfizer
Laurion Capital Management
Vanguard Group
Perceptive Advisors
Palo Alto Investors
683 Capital Management
Millennium Management
Jane Street
BlackRock
Renaissance Technologies
HealthInvest Partners AB
Geode Capital Management
Driehaus Capital Management
UBS Group
Marshall Wace

View all funds holding Pyxis Oncology